Overcoming Obstacles in Ovarian Dysgenesis 3 with Genetic Testing
Discover breakthroughs in ovarian dysgenesis 3 management with genetic testing. Explore early detection, personalized treatments, and informed family planning.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Probing Pancreatic Cancer: Genetic Testing Unveils New Avenues for Susceptibility to Type 4
Discover the role of genetic testing in early detection, personalized treatments, and familial insights for pancreatic cancer susceptibility to type 4.
Pinpointing Paragangliomas 5: The Power of Genetic Testing
Explore how genetic testing identifies SDHC mutations in Paragangliomas 5, enabling early detection, personalized treatment, and family risk assessment.
Powerful Pathways: Genetic Testing and Parkinson Disease 17
Unlock effective management of Parkinson Disease 17 through genetic testing, enabling early diagnosis, personalized treatments, and informed family planning strategies.
Peering into Parkinson Disease 18: Genetic Testing and Its Promising Potential
Explore how genetic testing aids in early detection, personalized treatment, and family planning for Parkinson Disease 18. Learn about its potential and challenges.
Perrault Syndrome 3: The Genetic Key to Understanding and Managing a Rare Disorder
Explore Perrault Syndrome 3, a rare genetic disorder linked to ERAL1 mutation. Learn how genetic testing aids diagnosis, family planning, and personalized treatment.
Pioneering Precision: Genetic Testing in Pigmented Nodular Adrenocortical Disease, Primary, 3
Explore the impact of genetic testing on diagnosing Pigmented Nodular Adrenocortical Disease, Primary, 3, and how it guides treatment and family planning.
Pioneering Paths in Pitt-Hopkins-like Syndrome 2: The Role of Genetic Testing
Unlock the potential of genetic testing for accurate diagnosis and personalized care in Pitt-Hopkins-like syndrome 2, focusing on NRXN1 gene mutations.